Neoadjuvant therapy affects tumor growth markers in early stage non-small-cell lung cancer

INTRODUCTION: While adjuvant therapy of early-stage non-small-cell lung cancer (NSCLC) is widely accepted, literature data concerning neoadjuvant treatment provide contradictory results with both improved and unaffected survival rates. Also, data concerning potential effects of neo-adjuvant therapy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chorostowska-Wynimko, J, Zaleska, J, Chabowski, M, Szpechcinski, A, Zych, J, Rudzinski, P, Langfort, R, Orlowski, T, Roszkowski-Sliz, K
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2009
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3521347/
https://ncbi.nlm.nih.gov/pubmed/20156723
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2047-783X-14-S4-42
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados